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Abstract
Preeclampsia is one of the leading causes of maternal and fetal morbidity and mortality. Due
to the lack of effective preventive measures, its prediction is essential to its prompt manage-
ment. This study aimed to develop models using machine learning to predict late-onset pre-
eclampsia using hospital electronic medical record data. The performance of the machine
learning based models and models using conventional statistical methods were also com-
pared. A total of 11,006 pregnant women who received antenatal care at Yonsei University
Hospital were included. Maternal data were retrieved from electronic medical records during
the early second trimester to 34 weeks. The prediction outcome was late-onset preeclampsia
occurrence after 34 weeks’ gestation. Pattern recognition and cluster analysis were used to
select the parameters included in the prediction models. Logistic regression, decision tree
model, naïve Bayes classification, support vector machine, random forest algorithm, and sto-
chastic gradient boosting method were used to construct the prediction models. C-statistics
was used to assess the performance of each model. The overall preeclampsia development
rate was 4.7% (474 patients). Systolic blood pressure, serum blood urea nitrogen and creati-
nine levels, platelet counts, serum potassium level, white blood cell count, serum calcium
level, and urinary protein were the most influential variables included in the prediction models.
C-statistics for the decision tree model, naïve Bayes classification, support vector machine,
random forest algorithm, stochastic gradient boosting method, and logistic regression models
were 0.857, 0.776, 0.573, 0.894, 0.924, and 0.806, respectively. The stochastic gradient
boosting model had the best prediction performance with an accuracy and false positive rate
of 0.973 and 0.009, respectively. The combined use of maternal factors and common antena-
tal laboratory data of the early second trimester through early third trimester could effectively
predict late-onset preeclampsia using machine learning algorithms. Future prospective stud-
ies are needed to verify the clinical applicability algorithms.
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Introduction
Preeclampsia, which affects 5–8% of pregnancies worldwide, is one of the leading causes of
maternal and fetal morbidity and mortality [1–3]. Maternal complications associated with pre-
eclampsia include placental abruption and acute kidney disease. In severe cases, preeclampsia
leads to eclamptic seizures and life-threatening hemolysis, elevated liver enzymes, and low
platelet count (HELLP) syndrome [4]. Fetal complications related to preeclampsia include
impaired fetal growth, neonatal respiratory distress syndrome, and stillbirth. Preeclampsia can
be classified as early-onset preeclampsia, which develops before 34 weeks’ gestation, and the
more common late-onset preeclampsia, which develops at or after 34 weeks’ gestation [5].
Despite the serious clinical consequences, there is currently no effective preventive measure
for preeclampsia. Close surveillance and early detection, which enable its prompt manage-
ment, comprise the main clinical management strategy. Therefore, studies have focused on
developing useful preeclampsia prediction methods [6]. A practical prediction model would
allow increased surveillance of at-risk patients and reduce surveillance of patients who are less
likely to develop preeclampsia. Although previous studies have analyzed clinical features and
evaluated biomarkers for effective prediction, few have demonstrated clinically sufficient prop-
erties [7–11].
Machine learning (ML) techniques provide the possibility to infer significant connections
between data items from diverse data sets that are otherwise difficult to correlate [12,13]. Due
to the vast amount and complex nature of medical information, ML is recognized as a promis-
ing method for diagnosing diseases or predicting clinical outcomes. Several ML techniques
have been applied in clinical settings and shown to predict diseases with higher accuracy than
conventional methods [14,15].
The specific aims of this study were to develop models using ML to predict late-onset pre-
eclampsia using hospital electronic medical record data and compare the performance of the
models developed from ML and conventional statistical methods.
Materials and methods
Study population
This study included 11,006 pregnant women who received antenatal care at Yonsei University
Healthcare Center (Severance hospital and Gangnam Severance hospital) in Seoul, Korea
between 2005 and 2017. Patients with pregnancy termination prior to 24 weeks’ gestation due
to miscarriage, fetal death, or early-onset preeclampsia or those who did not deliver at the
Yonsei University Healthcare Center were excluded from the study. Antenatal care and evalua-
tions were performed following common hospital protocols. The study protocol was approved
by the institutional review board of Yonsei University Health System (4-2017-0096). Informed
consent was waived by the institutional review boards owing to the retrospective study design.
Clinical and biochemical data collection
Demographic and laboratory data during the antenatal period were retrieved from electronic
medical records. Antenatal data were obtained for each individual repeatedly from the early
second trimester to gestational age of 34 weeks. Gestational age 14–17 weeks was considered as
early second trimester. The clinical data included age, blood pressure (BP), height, weight, and
gestational age. Maternal medical history of hypertension, diabetes, and previous preeclampsia
as well as obstetrical and social histories and medications prescribed during pregnancy were
also retrieved. The following biochemical laboratory data were also collected: blood urea nitro-
gen (BUN), serum creatinine, spot urine protein to creatinine ratio (UPCR), urine albumin to
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creatinine ratio, hemoglobin, fasting blood glucose, serum albumin, uric acid, total bilirubin,
aspartate transaminase (AST), alanine transaminase (ALT), total cholesterol, triglycerides,
high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol.
Study outcome
The study endpoint was the development of late-onset preeclampsia defined as new-onset
hypertension (diastolic BP� 90 mm Hg or systolic BP� 140 mm Hg measured on two occa-
sions at least 2 hours apart) accompanied by clinically significant proteinuria defined as one of
the following: random urine dipstick results of at least 1+ on two occasions or results of at least
2+; a 24-hour urine protein level� 300 mg; or a platelet count<100,000/μL, creatinine
level> 1.1 mg/dL, serum transaminase levels twice normal, or cerebral symptoms or pulmo-
nary edema occurring after 34 weeks’ gestation [16].
Selection of prediction model variables
For the repeated-measured data, such as BP, body weight, and laboratory data, significant vari-
ables to be included in the prediction models were delineated through pattern recognition and
cluster analysis (Fig 1) [17,18]. Pattern recognition and cluster analysis allows use of the value
of the variable itself and the changing pattern of the variable during the repeated measurement
period as analysis factors. The changes in individual variables during each of the 10-week win-
dows were patternized. Each window was shifted by a 2-week interval beginning from 14
weeks’ to 34 weeks’ gestational age. Subsequently, the patterned data were applied to the
sequential polynomial regression analysis. From this polynomial regression, coefficients were
estimated and used in the cluster analysis by the k-means algorithm. Odds ratios were calcu-
lated of each cluster. The variables with odds ratios> 12 were considered to have significant
pattern changes during the antenatal period and selected for inclusion in the prediction
models.
Primary analysis
The individuals included in the study were randomly divided into training (70% of sample)
and validation (30% of sample) sets [19]. Women who developed late-onset preeclampsia were
categorized into the preeclampsia group, while those who did not develop preeclampsia were
categorized into the no preeclampsia group. The characteristics at early second trimester were
compared between the preeclampsia and no preeclampsia groups. The normality of the
Fig 1. Flow chart of pattern recognition and cluster analysis based variable selection process for late-onset
preeclampsia prediction.
https://doi.org/10.1371/journal.pone.0221202.g001
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distribution was analyzed using the Kolomogorov-Smirnov test. Intergroup comparisons were
performed using Student’s t-test for normally distributed continuous variables, while variables
that did not show a normal distribution was compared using the Kruskal–Wallis test and pre-
sented as median with interquartile range. For clinically important candidate variables with
missing data, multiple imputation was used, with 25 imputed data sets generated using fully
conditional specification methods to generate the final estimates.
Six methods were used for prediction model development and compared. The repeated
measured values of the variables selected from the pattern recognition and cluster analysis
were used in the prediction models. These data included those from antenatal evaluations
starting from early trimester until gestational age of 34 weeks. In addition to these repeated
measured variables, non-repeated measured variables such as maternal medical history, obstet-
rical and social history, and medication prescription history during pregnancy were also
included in the prediction models. The prediction outcome was late-onset preeclampsia occur-
rence after 34 weeks’ gestational age. The methods used for prediction model construction
were logistic regression (LR), decision tree model (DT), naïve Bayes classification (NBC), sup-
port vector machine (SVM), random forest algorithm (RF), and stochastic gradient boosting
method (SGB) [20–25]. For LR, variables were entered into the model by backward elimina-
tion. For RF, the number of decision trees was set to 250. The number of repetition boosts in
the SGB was also set to 250. For RF and SGB, the number of variables to be sampled as split





prediction models were implemented using R programming language (software 3.3.1 (http://
www.R-project.org).). To assess the relative importance of the selected variables in each pre-
diction model, absolute t-score was used for the LR model, 1-accuracy for model excluding the
relevant variable was used for the NBC model, and IncNodePurity was used in DT, SVM, RF,
and SGB models.
Each model’s performance was evaluated and compared using the validation data set. The
receiver operating characteristic curve and area under the curve were used to evaluate the
model’s ability to predict late-onset preeclampsia. Model calibration was evaluated using plots
of predicted vs. observed rates of preeclampsia development. C-statistics was used to assess the
performance of each prediction model.
Results
Clinical characteristics
The clinical characteristics of study subjects obtained at early second trimester are shown in
Table 1. Among the 11,006 enrolled individuals, preeclampsia was subsequently diagnosed in
474 (4.7%) women after 34 weeks’ of gestation. Subjects who developed preeclampsia were
older than those who did not develop preeclampsia. Parity number did not differ between the
two groups. Systolic and diastolic BP were both significantly higher in those who developed
preeclampsia than in those who did not. Regarding maternal medical history, subjects who
developed preeclampsia were more likely to have chronic hypertension and have been diag-
nosed with preeclampsia in previous pregnancies than those who did not develop preeclamp-
sia. When laboratory test results were compared, UPCR, total bilirubin, AST, ALT, BUN,
creatinine, and hemoglobin levels at early second trimester were higher but platelet count was
lower in subjects who developed preeclampsia than in those who did not.
Table 2 summarizes the clinical characteristics of the study subjects at delivery. Maternal
weight was higher and systolic and diastolic BP were significantly higher in women who devel-
oped preeclampsia than in those who did not. UPCR, AST, ALT, BUN, and serum creatinine
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levels were higher at delivery while platelet counts were lower in subjects who were diagnosed
with preeclampsia than in those who were not.
Variable influence on prediction
Using the pattern recognition and cluster analysis, the influence of each variable on prediction
was evaluated. Among the assessed variables, the 14 most influential factors were included in
the prediction models. Systolic BP, followed by serum BUN and creatinine level, and platelet
count were the most important variables. Interestingly, white blood cell count, serum calcium
level, and serum magnesium level were also delineated as influential variables (Fig 2). The rela-
tive importance of the selected variables in each prediction model are described in S1 Table.
Model performance
Calibration plots with respective C-statistics of DT, NB, SVM, RF, SGB, and LR models for
predicting preeclampsia are shown in Fig 3. Notably, the C-statistics value model for predict-
ing preeclampsia was highest in the SGB model, showing a value of 0.924. The C-statistics val-
ues for each of the DT, NB, SVM, RF, and LR were 0.857, 0.776, 0.573, 0.894, and 0.860,






Maternal age, years 38.9 ± 5.0 44.1 ± 20.2 <0.001
Parity number 1.9 ± 1.1 2.0 ± 1.1 0.07
Height, cm 160.9 ± 7.1 159.8 ± 7.8 <0.001
Maternal weight at pregnancy, kg 57.8 ± 10.0 60.1 ± 11.8 <0.001
SBP, mmHg 111.73 ± 8.7 116.7 ± 12.3 <0.001
DBP, mmHg 67.8 ± 6.5 71.6 ± 9.2 <0.001
Maternal history, n (%)
Smoking, n (%) 36 (0.3) 4 (0.9) 0.05
Alcohol, n (%) 108 (1.0) 7 (1.6) 0.26
Hypertension 154 (1.4) 75 (16.8) <0.001
Diabetes 425 (4.0) 18 (4.0) 0.98
Preeclampsia 5 (0.1) 6 (1.3) <0.001
Laboratory data
WBC, 103/uL 9.01 ± 4.17 11.04 ± 3.45 <0.001
Hemoglobin, g/dL 11.6 ± 1.4 13.5 ± 12.4 <0.001
Platelet counts, 109/L 200.1 ± 57.0 195.5 ± 63.3 <0.001
BUN, mg/dL 5.7 ± 3.2 9.9 ± 8.2 <0.001
Creatinine, mg/dL 0.4 ± 0.2 0.7 ± 0.7 <0.001
Total bilirubin, mg/dL 0.3 ± 0.2 0.4 ± 0.4 <0.001
AST, IU/L 15.8 ± 18.4 24.8 ± 41.5 <0.001
ALT, IU/L 12.8 ± 16.7 20.0 ± 29.7 <0.001
Potassium, mEq/L 4.1 ± 0.3 4.3 ± 0.2 0.36
TCO2, mEq/L 21.9 ± 2.1 20.6 ± 2.6 0.17
Calcium, mg/dL 8.5 ± 0.5 8.7 ± 1.1 0.43
Magnesium, mg/dL 1.2 ± 0.1 1.6 ± 0.0 0.56
UPCR, g/gCr 0.09 [0.02–0.12] 0.20 [0.08–0.26] 0.87
Data are presented as mean ± standard deviation or number (%)
Abbreviation: SBP, systolic blood pressure; DBP, diastolic blood pressure; UPCR, urine protein to creatinine ratio
https://doi.org/10.1371/journal.pone.0221202.t001
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respectively. When the prediction performances were compared among the prediction models,
the SGB model had the best performance for predicting preeclampsia. The overall accuracy of
the SGB model was 0.973, false positive rate was 0.009, and detection rate reached 0.771
(Table 3).






Maternal weight at delivery, kg 62.8 ± 9.3 64.0 ± 10.9 <0.001
SBP, mmHg 113.5 ± 12.0 145.0 ± 22.6 <0.001
DBP, mmHg 68.4 ± 8.9 89.8 ± 15.4 <0.001
Laboratory data
WBC, 103/uL 9.4 ± 2.8 11.0 ± 4.7 <0.001
Hemoglobin, g/dL 11.8 ± 1.3 11.9 ± 1.8 0.15
Platelet counts, 109/L 228.8 ± 63.9 207.3 ± 79.3 <0.001
BUN, mg/dL 7.8 ± 2.5 12.4 ± 5.3 <0.001
Creatinine, mg/dL 0.5 ± 0.2 0.7 ± 0.3 <0.001
Total bilirubin, mg/dL 0.5 ± 0.2 0.5 ± 0.8 0.51
AST, IU/L 18.3 ± 0.5 54.7 ± 20.7 <0.001
ALT, IU/L 12.9 ± 0.4 37.8 ± 9.9 <0.001
Potassium, mEq/L 4.1 ± 0.3 4.3 ± 0.3 <0.001
TCO2, mEq/L 21.8 ± 2.2 20.9 ± 2.8 <0.001
Calcium, mg/dL 8.7 ± 0.4 8.4 ± 0.7 <0.001
Magnesium, mg/dL 1.5 ± 0.5 1.6 ± 0.7 0.85
UPCR, g/gCr 0.15 [0.08–0.21] 0.36 [0.20–0.40] <0.001
Data are presented as mean ± standard deviation or number (%)
Abbreviation: SBP, systolic blood pressure; DBP, diastolic blood pressure; UPCR, urine protein to creatinine ratio
https://doi.org/10.1371/journal.pone.0221202.t002
Fig 2. Normalized importance of the selected variables for late-onset preeclampsia prediction models. The plot
shows relative importance of the variables in random forest model. IncNodePurity reflects the reduction in entropy,
which is the uncertainty, due to sorting of the attribute. Abbreviation: SBP, systolic blood pressure; WBC, white blood
cell; UPCR, urine protein to creatinine ratio; UACT, urine albumin to creatinine ratio.
https://doi.org/10.1371/journal.pone.0221202.g002
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Discussion
In this study, use of ML algorithms resulted in improved prediction performance of pre-
eclampsia development compared to traditional statistical models. The accuracy and detection
rate of the SGB model was superior to other prediction algorithms. In addition, influential var-
iables for predicting preeclampsia were delineated which included several novel parameters.
The development of easy-to-use preeclampsia prediction methods has been a challenging
subject. In this study, although the 2nd trimester characteristics did show statistically different
values between the preeclampsia developing and non-developing group, the differences were
minimal and not clinically noticeable. These clinically similar 2nd trimester characteristics are
one of the main reasons that it is practically difficult to distinguish those who would develop
preeclampsia from those who would not at this early time point of pregnancy. The fact that the
Fig 3. Receiver operating characteristic curves of late-onset preeclampsia prediction models. C-statistics for each
prediction model are presented in the graph. Abbreviation: DT, decision tree; NBC, naïve Bayes classification; SVM,
support vector machine; RF, random forest; SGB, stochastic gradient boosting; LR, logistic regression.
https://doi.org/10.1371/journal.pone.0221202.g003
Table 3. Comparison of prediction performances for late-onset preeclampsia development.
Models Accuracy Sensitivity Specificity Detection Rate
LR 0.862 0.703 0.870 0.209
DT 0.874 0.648 0.885 0.215
NBC 0.899 0.500 0.918 0.229
SVM 0.892 0.137 0.928 0.085
RF 0.923 0.679 0.935 0.336
SGB 0.973 0.603 0.991 0.771
Abbreviation: LR, logistic regression; DT, decision tree; NBC, naïve Bayes classification; SVM, support vector machine; RF, random forest; SGB, stochastic gradient
boosting
https://doi.org/10.1371/journal.pone.0221202.t003
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pathogenesis of preeclampsia is complex and involves heterogeneous factors is one of the main
causes of this difficulty [26,27]. Nonetheless, repeated attempts have been made to efficiently
predict preeclampsia, which would lead to its early detection and prompt management. Identi-
fying risk factors has been the most frequent approach to increase disease predictability. A pre-
vious history of preeclampsia, known chronic kidney disease, hypertension, diabetes,
autoimmune disorders including systemic lupus erythematous and anti-phospholipid syn-
drome, maternal age> 40 years, and a body mass index> 35 kg/m2 are factors that have been
reported to be associated with an increased preeclampsia development rate [28–31]. However,
preeclampsia often occurs even in women without these risk factors, and additional strategies
for its effective screening are limited. Several biomarkers have been also proposed to supple-
ment the screening process for preeclampsia [32,33]. However, even with the help of these bio-
markers, only 30% of cases of preeclampsia are predicted in advance [34]. The prediction
model in this study effectively predicted the development of preeclampsia using demographic
factors and antenatal laboratory data, which can be easily obtained in regular clinical practice.
Even without the supplementation of biomarkers, the overall accuracy of the SGB model in
this study was relatively high with a false positive rate of only 0.006. Therefore, the ML-based
model proposed in this study could be used as a practical preeclampsia screening method dur-
ing the antenatal period.
Several novel factors were found to impact preeclampsia prediction. Parameters that have
been traditionally reported to be related to preeclampsia development such as BP, white blood
cell count, creatinine level, liver function, and urinary protein were also determined to be
influential factors in preeclampsia prediction. Interestingly, serum potassium levels were
among the most important factors related with preeclampsia development. Although not thor-
oughly investigated, the relationship between serum potassium levels and hypertensive disor-
ders during pregnancy has been often recognized. In a recent observational study of 8,114
deliveries, serum potassium levels during the first half of pregnancy was associated with a
higher risk of severe preeclampsia [35]. Potassium homeostasis during pregnancy is affected
by the activities of aldosterone and progesterone, both of which are known to play key roles in
systemic vasodilatation [36]. Therefore, elevated serum potassium levels in pregnant women
may be a surrogate for aldosterone and progesterone derangement, which could in turn be
correlated with preeclampsia development. Serum calcium and magnesium levels were also
closely associated with preeclampsia development [37]. This relationship has been proposed in
several previous studies. Although controversial, low serum calcium levels during the antenatal
period have been noticed in preeclampsia patients [38]. In addition, plasma magnesium levels
were recently found to be higher in cases of mild and severe preeclampsia than in normal preg-
nancies [39]. The fact that calcium and magnesium play key roles in vascular smooth muscle
constriction could explain this relationship.
The variables included in the prediction model were identified through pattern recognition.
Pattern recognition and clustering was performed for repeated measured variables of regular
antenatal evaluations preformed from early second trimester to 34 weeks’ of gestation. Previ-
ous studies investigating the relationship of clinical variables and preeclampsia development
mostly used the mean value of a variable during a certain period. These investigations did not
account for the fluctuation variability of the values. Recently, not only the mean value but also
the fluctuation variability of a biomedical parameter has been suggested to have important
clinical implications. Increased fluctuations in body weight and BP were found to increase the
risk of cardiovascular diseases, while high variability in serum glucose levels were correlated
with increased retinopathy risk in diabetic patients [40–42]. By incorporating the repeated
measured values of the variables during the early second and third trimester period in the pat-
tern recognition analysis, the value of the parameter itself as well as the changing pattern
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during the evaluation period was included as an analyzable factor. The pattern recognition
and cluster analysis used with time series data allows the utilization of multiple aspects of a var-
iable. In addition to using each value of the variables at different time points of a continuous
time line, the changing patterns of the variables during the repeated measurement period
could also be considered as a meaningful factor. This permits variables to be distinguished
even if the values of the two variables are the same at a given point in time, as long as the pat-
tern of change in the values in the continuous measurement is different. Such distinction
would be important in interpreting repeated measured biological data. In a continuously
increasing situation against a steadily decreasing situation, the same test value would undoubt-
edly have different clinical significance. This capability has enabled the successful use of pat-
tern recognition to explore and exploit not only high-throughput measurement data [43], but
also clinical data. Several recent investigations have used pattern recognition analysis for pre-
dicting adverse outcomes in chronic diseases [44–46]. In addition, unlike most of the evalua-
tions assessing the association between biomarkers and preeclampsia development in which a
hypothesis-based approach is used, a more objective and data-centric approach was possible
by the application of pattern recognition. It should be noted that such an analytical approach
has not been used before to predict preeclampsia in a large cohort of pregnant women.
This study has several limitations. First, most of the women were not included in the ante-
natal evaluation program until early second trimester. Therefore, first-trimester data could not
be obtained. Although some reports have shown that early maternal changes were noticeable
in women who develop preeclampsia [47]. most previous investigations have reported signifi-
cant changes in the second and third trimesters. In addition, even without including first-tri-
mester data, the predictive power of the SGB model was adequate. Second, the number of
preeclampsia events was relatively smaller than in the control group. Nonetheless, considering
the fact that the incidence of preeclampsia is 5–8% of all pregnancies, the number of pre-
eclampsia cases was suitable considering the total study sample size [1]. In addition, the num-
ber of patients included in the present study was still larger than those of previous reports
evaluating the association between clinical markers and preeclampsia development. Third,
although antenatal evaluations were performed following the common protocol of our mater-
nity care center, the evaluation intervals varied based on the participants’ symptoms and con-
ditions. This could have influenced the prediction models. Nonetheless, since normal
antenatal evaluations would be performed in a similar manner, the results of this study could
have an advantage in being applied to real-world practice environments.
Conclusions
The combination of maternal factors and common antenatal laboratory data from the early
second and early third trimester using ML algorithms could effectively predict late-onset pre-
eclampsia. Such algorithms could be applied in routine antenatal care to improve maternal
and fetal outcomes of preeclampsia. Future studies prospectively verifying the accuracy of the
proposed prediction algorithms are needed.
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